DT Cloud Acquisition Corp. Updates on Maius Pharmaceutical Merger, Announces $150,000 Private Placement with Pubco
DT Cloud Acquisition Corp. announced an update regarding its previously disclosed business combination with Maius Pharmaceutical Co., Ltd. According to a recent filing, DT Cloud Acquisition Corp. has entered into a Subscription Agreement with Maius, Pubco, and an investor. Under this agreement, the investor will purchase 15,000 ordinary shares of Pubco at $10.00 per share in a private placement. The completion of this private placement is contingent on the closing of the broader business combination transaction involving DT Cloud Acquisition Corp., Maius, and related entities. The company stated that these steps are part of its ongoing efforts to finalize the transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DT Cloud Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016335), on September 30, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。